The report will be delivered in 2-3 business days.

Lung Cancer Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : October 2019 | SKU CODE : 7195 | Format :


The lung cancer drugs market consists of sales of lung cancer drugs. Lung cancer is a type of cancer that decreases the ability of lungs to supply oxygen to the bloodstream beacause of uncontrolled growth of tissues in the lung. Some of the possible treatments for lung cancer include surgery, chemotherapy, radiation therapy and targeted therapy. On the basis of the size of the tumor cells, lung cancer is broadly divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).

The global lung cancer market was valued at about $17.6 billion in 2018 and is expected to grow to $22.98 billion at a CAGR of 6.9% through 2022.

The rising prevalence rate of lung cancer is a major driver for the lung cancer market. This is mainly because an increase in prevalence and incidence rate of lung cancer cases propels the need for drugs that enable effecient and fast treatment of the disease. It also drives the industry to maintain a strong pipeline of drugs. According to the International Agency for Research on Cancer (IARC), cancer led to around 9.6 million deaths in 2018, out of which, lung cancer was responsible for the largest number of deaths (1.8 million deaths, 18.4% of the total).

Increasing use of biologics and targeted therapies is a major restraint for the lung cancer market. This is because chemical lung cancer drugs come with myriads of side effects and have a toxic effect on the body. Chemical drugs lack cell specificity, i.e., they destroy even the normal body cells along with cancer infected cells. While biologic drugs are highly targeted and work on cancer infected cells only. Biologic drugs are also very efficient with no side-effects. Clinical studies have also found that the probability of success of biologic drugs is much higher than the conventional chemical drugs. For example, Cetuximab, Gefitinib and Afatinib are lung cancer biologic drugs which specifically target only the muted form of tumours and do not destroy the normal body cells.

Targeted drug therapy in combination with other therapies is an emerging trend in the lung cancer market. It involves the use of immunotherapy drugs combined with other therapies such as chemotherapy that help in early diagnosis, prevention and treatment of the disease. In this regard, drug manufacturers are developing targeted drug therapies for better diagnosis and treatment of lung cancer. For example, in 2018, Merck and Co. developed pembrolizumab, which is a drug that helps the immune system to detect and fight cancer cells when used in addition to chemotherapy. This combination therapy showed an improvement in lung cancer status in patients. The drug is a major product of Merck and Co., and is sold under the brand name Keytruda.

The FDA's guidelines for lung cancer drugs are mentioned within the Code for Federal Regulations (CFR) title number 21 under part 312, which contains sub-parts from 'A' to 'I'. The sub-part 'E' deals with the procedures designed to push the development, evaluation and marketing of drugs related to therapies aimed to treat persons with life-threatening illnesses such as lung cancer. The sub part 'E' also includes guidelines for monitoring and evaluation of clinical trials of lung cancer drugs and other cancer drugs by agency officials to determine whether new treatments are safe and effective, or better than existing treatments. All drug manufacturers are required to abide to these regulations by the FDA. Hence, regulations such as these would also keep a check on manufacturers of lung cancer drugs.

Major players in the market are Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc.

    1. Executive Summary

    2. Lung Cancer Drugs Market Characteristics

    3. Lung Cancer Drugs Market Size And Growth

    3.1. Global Lung Cancer Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Lung Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Lung Cancer Drugs Market Segmentation

    4.1. Global Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Small cell lung cancer (SCLC)

    Non-small cell lung cancer (NSCLC)

    4.2. Global Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Clinics

    Others

    4.3. Global Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Gemzar

    Paraplatin

    Taxotere

    Navelbine

    Avastin

    Tarceva

    Iressa

    Others

    5. Lung Cancer Drugs Market Regional And Country Analysis

    5.1. Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Lung Cancer Drugs Market  

    6.1. Asia-Pacific Lung Cancer Drugs Market Overview  

    6.2. Asia-Pacific Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Lung Cancer Drugs Market  

    7.1. China Lung Cancer Drugs Market Overview  

    7.2. China Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Lung Cancer Drugs Market  

    8.1. India Lung Cancer Drugs Market Overview  

    8.2. India Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Lung Cancer Drugs Market  

    9.1. Japan Lung Cancer Drugs Market Overview  

    9.2. Japan Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Lung Cancer Drugs Market  

    10.1. Australia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Lung Cancer Drugs Market  

    11.1. Indonesia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Lung Cancer Drugs Market  

    12.1. South Korea Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Lung Cancer Drugs Market  

    13.1. Western Europe Lung Cancer Drugs Market Overview

    13.2. Western Europe Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Lung Cancer Drugs Market  

    14.1. UK Lung Cancer Drugs Market Overview

    14.2. UK Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Lung Cancer Drugs Market  

    15.1. Germany Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Lung Cancer Drugs Market  

    16.5. France Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Lung Cancer Drugs Market  

    17.1. Eastern Europe Lung Cancer Drugs Market Overview

    17.2. Eastern Europe Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Lung Cancer Drugs Market  

    18.1. Russia Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Lung Cancer Drugs Market  

    19.1. North America Lung Cancer Drugs Market Overview

    19.2. North America Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Lung Cancer Drugs Market  

    20.1. USA Lung Cancer Drugs Market Overview

    20.2. USA Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Lung Cancer Drugs Market  

    21.1. South America Lung Cancer Drugs Market Overview

    21.2. South America Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Lung Cancer Drugs Market  

    22.1. Brazil Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Lung Cancer Drugs Market  

    23.1. Middle East Lung Cancer Drugs Market Overview

    23.2. Middle East Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Lung Cancer Drugs Market  

    24.1. Africa Lung Cancer Drugs Market Overview

    24.2. Africa Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Lung Cancer Drugs Market Competitive Landscape And Company Profiles

    25.1. Lung Cancer Drugs Market Competitive Landscape

    25.2. Lung Cancer Drugs Market Company Profiles

    25.2.1. Bristol-Myers Squibb Company

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Merck & Co.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. F. Hoffmann-La Roche Ltd

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Novartis AG

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Pfizer Inc.

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Lung Cancer Drugs Market

    27. Lung Cancer Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Lung Cancer Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Australia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Indonesia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: South Korea, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Western Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: UK, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: UK, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Germany, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: France, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: France, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Russia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: North America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: North America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: USA, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: USA, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: South America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: South America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: Brazil, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Middle East, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Africa, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: Bristol-Myers Squibb Company Financial Performance
  • Table 66: Merck & Co. Financial Performance
  • Table 67: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 68: Novartis AG Financial Performance
  • Table 69: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Lung Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Lung Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Australia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: South Korea, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: UK, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Germany, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: France, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: France, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Russia, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: North America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: USA, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: South America, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: Brazil, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Middle East, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Africa, Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Lung Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Lung Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: Bristol-Myers Squibb Company Financial Performance
  • Figure 66: Merck & Co. Financial Performance
  • Figure 67: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 68: Novartis AG Financial Performance
  • Figure 69: Pfizer Inc. Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)